Section R4-23-501. Controlled Substances Prescription Monitoring (CSPMP) Program Registration and Database Access

A.      Under A.R.S. § 36-2606, a medical practitioner who is issued a license under A.R.S. Title 32, Chapter 7, 11, 13, 14, 15, 16, 17, 21, 25, or 29 and possesses a current DEA registration under the Federal Controlled Substances Act shall have a cur- rent CSPMP registration issued by the Board.

B.       Application.

1.        An applicant for CSPMP registration shall:

a.         Submit a completed application for CSPMP registra- tion electronically or manually on a form furnished by the Board, and

b.        Submit with the application form the documents specified in the application form.

2.        The Board office shall deem an application form received on the date the Board office electronically or manually date-stamps the form.

C.      Registration. Within seven business days of receipt of a com- pleted application specified in subsection (B), the Board office shall determine whether an application is complete. If the application is complete, the Board office shall issue a registra- tion number and provide a current registration certificate to the applicant by mail or electronic transmission. If the application is incomplete, the Board office shall issue a written notice of incompleteness. An applicant with an incomplete application shall comply with the requirements of R4-23-202(F).

D.      Registration renewal. As specified in A.R.S. § 36-2606(C), the Board shall automatically suspend the registration of any reg- istrant that fails to renew the registration on or before May 1 of the year in which the renewal is due. The Board shall vacate a suspension if the registrant submits a renewal application. A suspended registrant with CSPMP database access credentials is prohibited from accessing information in the prescription monitoring program database.

E.       CSPMP database access.

1.        A medical practitioner that chooses to use the CSPMP database shall request access from the CSPMP Director by completing an access user registration form electroni- cally. Upon receipt of the access user registration form, the CSPMP Director or designee shall issue access cre- dentials provided the medical practitioner is in compli- ance with the registration requirements of this Section.

2.        A pharmacist that chooses to use the CSPMP database shall request access from the CSPMP Director by com- pleting an access user registration form electronically. Upon receipt of the access user registration form, the CSPMP Director or designee shall issue access creden- tials provided the pharmacist has a current active pharma- cist license.

3.        A medical practitioner or pharmacist who is not licensed in Arizona may request access from the CSPMP Director by:

a.         Completing an access user registration form elec- tronically;

b.        Printing the access user registration form;

c.         Having the access user registration form signed and notarized; and

d.        Mailing the notarized access user form along with a current copy of the applicant's nonresident state license and driver's license. Upon receipt of the notarized access user registration form and other required documents, the CSPMP Director or desig- nee shall issue access credentials provided the non- resident licensed medical practitioner or pharmacist credentials show an current active license in another state.

Historical Note

Former Rule 5.2110; Amended effective August 9, 1983 (Supp. 83-4). Amended by final rulemaking at 8 A.A.R. 4898, effective January 5, 2003 (Supp. 02-4). Recodified

to R4-23-801 at 9 A.A.R. 4011, effective August 18, 2003 (Supp. 03-3). New Section made by final rulemak- ing at 14 A.A.R. 3410, effective October 4, 2008 (Supp.

08-3). Amended by final rulemaking at 19 A.A.R. 94,

effective March 10, 2013 (Supp. 13-1). Section expired

under A.R.S. § 41-1056(J) at 20 A.A.R. 133, effective August 30, 2013 (Supp. 14-1). New Section made by

final rulemaking at 20 A.A.R. 1359, effective August 2,

2014 (Supp. 14-2).